CLINICAL_TRIALS
trial_result
· 2017-10-04
Clinical Trial Update: A Safety Study of VIMOVO in Adolescents With Juvenile Idiopathic Arthritis (JIA) [Phase 4]
Summary
Phase 4 safety study of VIMOVO in adolescents with Juvenile Idiopathic Arthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Amgen | Conditions: Juvenile Idiopathic Arthritis (JIA) | Phase 4 | Status: COMPLETED | Results posted: 2017-10-04